| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/17/2004 | US6777195 Pharmaceutical dipeptide compositions and methods of use thereof: immunostimulants |
| 08/17/2004 | US6777176 Target system |
| 08/12/2004 | WO2004026814A3 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 08/12/2004 | WO2004003561A9 Peptide rod amphiphiles and self-assembly of same |
| 08/12/2004 | US20040158092 for example, N-(N-acetyl-L-cysteinyl)-S-acetylcysteamine; by protecting the N-acyl-L-cysteine to form an intermediate compound and then coupling intermediate compound with S-acylcysteamine hydrochloride or with thiazolidine |
| 08/12/2004 | US20040157834 Somatostatin antagonists and agonists that act at the SST subtype 2 receptor |
| 08/12/2004 | US20040157782 killing or inhibiting the multiplication of tumor cells or cancer cells or as an immunosuppresant |
| 08/12/2004 | US20040157781 Peptide binding the KLVFF-sequence of amyloid-beta |
| 08/12/2004 | US20040157264 Piperazine melanocortin-specific compounds |
| 08/11/2004 | EP1445262A1 PEPTIDE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF |
| 08/11/2004 | EP1444201A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443922A1 Mch antagonists for the treatment of obesity |
| 08/11/2004 | EP1443816A2 Methods of treating disorders related to apoe |
| 08/11/2004 | EP1140918B1 Thrombin inhibitors |
| 08/11/2004 | EP0832101B1 Urethane mediated, gst specific molecular release systems |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1161374C Cyclopeptides of formulal |
| 08/11/2004 | CN1161373C Peptide and method for obtg. same |
| 08/10/2004 | US6774212 For therapy of viral infection or as an assay standard or reagent |
| 08/10/2004 | US6774102 Extracorporeal endotoxin removal method |
| 08/05/2004 | WO2004065610A1 METHOD FOR PRODUCING α- L-ASPARTYL-L-PHENYLALANINE-β-ESTER AND METHOD FOR PRODUCING α-L-ASPARTYL-L-PHENYLALANINE-α-METHYL ESTER |
| 08/05/2004 | WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/05/2004 | WO2004065411A2 Peptides |
| 08/05/2004 | WO2004064770A2 Use of smad3 inhibitor in the treatment of fibrosis dependent on epithelial to mesenchymal transition as in the eye and kidney |
| 08/05/2004 | WO2004037169A3 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/05/2004 | WO2004014882A3 Proteasome inhibitors : peptide derivatives having c-terminal heteroaryl groups |
| 08/05/2004 | WO2003087054A3 Methods for identifying compounds that modulate enzymatic activity |
| 08/05/2004 | WO2003044045A3 Peptides promoting cell adherence, growth and secretion |
| 08/05/2004 | WO2003007689A3 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 08/05/2004 | US20040152703 Controlling fertility; contraceptiives |
| 08/05/2004 | US20040152697 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 08/05/2004 | US20040152134 Eating disorders; sexual disorders; erectile dysfunction |
| 08/05/2004 | US20040152078 Genetic engineering |
| 08/05/2004 | DE19737245B4 Faseriger Mikrotubus aus einer Oligoglycinverbindung und Verfahren zur Herstellung des faserigen Mikrotubus Fibrous Mikrotubus from a Oligoglycinverbindung and method for producing the fibrous Mikrotubus |
| 08/05/2004 | CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
| 08/04/2004 | EP1442296A2 Biological assay detection method |
| 08/04/2004 | EP1442050A2 Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 08/04/2004 | EP1442049A2 Substituted amino ketone compounds |
| 08/04/2004 | EP1441750A2 Linear and cyclic melanocortin receptor-specific peptides |
| 08/04/2004 | EP1441720A1 Inhibitors of serine protease, particularly hepatitis c virus ns3-ns4a protease, incorporating a fused ring system |
| 08/04/2004 | EP1311535B1 Metal ion assisted n- n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester isomer resolution |
| 08/04/2004 | EP1127071B1 Compounds with growth hormone releasing properties |
| 08/04/2004 | EP0981542B1 20(s) camptothecin glycoconjugates |
| 08/04/2004 | CN1518558A Peptides and/or proteins and use thereof for production of therapeutic and/or prophylactic medicament |
| 08/04/2004 | CN1160075C Use of heterocyclic amide compound for preparing IgE antibody production inhibitors |
| 08/03/2004 | US6770627 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and p 53 |
| 08/03/2004 | US6770259 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
| 08/03/2004 | CA2233457C Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 07/29/2004 | WO2004063214A2 Antibodies that specifically recognize sumo-conjugated proteins |
| 07/29/2004 | WO2004062568A2 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent |
| 07/29/2004 | WO2004043993A3 Novel ampiphilic fluorocarbon molecular vectors for biomedical and medical use |
| 07/29/2004 | WO2004041297A3 Modified cytokines for use in cancer therapy |
| 07/29/2004 | WO2004031215A3 Method for synthesizing peptides comprising at least one glycine molecule |
| 07/29/2004 | WO2004015392A3 Improved method to identify targeting molecules |
| 07/29/2004 | WO2003099853A3 Petide amidation process |
| 07/29/2004 | US20040147567 Control appetites; obesity; eating disorders |
| 07/29/2004 | US20040147536 Remedies for sepsis |
| 07/29/2004 | US20040147483 For therapy of viral infection |
| 07/29/2004 | US20040147456 For therapy and prophylaxis of thrombolytic condition |
| 07/29/2004 | US20040146959 for detecting the phosphorylation activity of one or more protein kinases in a sample; fluorescent dye linked phosphorylable substrate |
| 07/29/2004 | US20040146552 Lipopeptides that are immunomodulators encapsulated as liposomes or free-form for the treatment of neoplasia and in reducing chemotherapeutically induced cellular pathology, including mucositis |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2551593A1 Affinity screening using "one-bead-one-compound" libraries |
| 07/28/2004 | EP1440977A1 Improved process for the preparation of diamidic derivatives of the tripeptid KPV |
| 07/28/2004 | EP1440976A1 Modified aminoacids, pharmaceuticals containing these compounds and method for their production |
| 07/28/2004 | EP0805816B1 Compounds with growth hormone releasing properties |
| 07/28/2004 | CN1515674A Biological pure culture for Nocardia |
| 07/28/2004 | CN1515587A Technetium and rhenium coupled tri-and tetrapeptide combinational library, tis active peptide compound and its foundation method |
| 07/28/2004 | CN1515586A Diisopropoxyphosphorylated dipeptide methyl ester, its preparation and application |
| 07/28/2004 | CN1515570A Preparation method of pyrazolo [4,3-C] pyridine-3-ketone L-tartate |
| 07/28/2004 | CN1515550A Thrombosis resisting preparation |
| 07/28/2004 | CN1159289C C-terminal modified oxamyl dipetides as inhibitors of the ICE/ced-3 family of cystenine proteases |
| 07/28/2004 | CN1159286C Preparation of 1-alkoxycarbonyl-3-phenylpropyl derivatives |
| 07/27/2004 | US6767992 Used for chemotherapy against cancers and is used especially for melanomas |
| 07/27/2004 | US6767991 Peptides and analogs thereof; viral protease inhibitors, pharmaceutical compositions containing such peptides and ribavirin |
| 07/27/2004 | US6767990 Peptides used as angiotensin converting enzyme inhibitor and preparation process thereof |
| 07/27/2004 | US6767897 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 07/22/2004 | WO2004060916A2 Peptide compound containing boron |
| 07/22/2004 | WO2004060913A2 Heteroaryl peptidomimetics as thrombin receptor antagonists |
| 07/22/2004 | WO2004060791A1 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 07/22/2004 | WO2004060264A2 Metastin derivatives and their use |
| 07/22/2004 | WO2004044000A3 Compounds and methods for modulating functions of classical cadherins |
| 07/22/2004 | WO2004043339A3 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 07/22/2004 | WO2004007661A3 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 07/22/2004 | US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst |
| 07/22/2004 | US20040143016 Catalytic antioxidants and methods of use |
| 07/22/2004 | US20040142938 for treating diabetes and related diseases |
| 07/22/2004 | US20040142909 Colchinol derivatives as angiogenesis inhibitors |
| 07/22/2004 | US20040142878 N-cycloalkylglycines as HIV protease inhibitors |
| 07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
| 07/22/2004 | US20040142876 peptidic phenethylamides; non-covalent inhibitors of serine protease |
| 07/22/2004 | US20040142875 "metastin" is the ligand to a G-protein-coupled orphan receptor known as OT7T175 or AXOR12; prodrug; treating cancer, hydatid mole, invasive mole, miscarriage, fetal hypoplasia, sugar dysbolism, lipid dysbolism or labor induction in a mammal |
| 07/22/2004 | US20040142874 peptides which modulate anaphylactic, endotoxic and inflammatory reactions in mammals; obtained from mammalian submandibular glands |
| 07/22/2004 | US20040142860 Central nervous system-derived immune privilege factor and uses thereof |
| 07/22/2004 | US20040142389 Immunoglobulin which specifically binds gastrointestinal tract (GIT) transport receptors for use as tools in tissue targeted therapies; drug screening and delivery |
| 07/22/2004 | US20040142385 Cell wall mannoproteins and active epitopes from candida albicans and antibodies recognizing them |
| 07/22/2004 | US20040141939 Cosmetic or dermatological use of peptides for promoting adhesion between skin cells |
| 07/22/2004 | CA2512553A1 Metastin derivatives and their use |
| 07/22/2004 | CA2508891A1 Heteroaryl peptidomimetics as thrombin receptor antagonists |